Caroline Litchfield insider trades: Merck (MRK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Caroline reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | MRK | ↓ Sell | 41,997 | $119.61 | $5.0M | Direct | Feb 6, 2026 (2d) |
| Feb 14, 2024 | MRK | ↓ Sell | 38,291 | $125.50 | $4.8M | Direct | Feb 15, 2024 (1d) |
| Nov 4, 2021 | MRK | ↓ Sell | 18,335 | $91.00 | $1.7M | Direct | Nov 5, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRK insiders
Open-market trades in the last 12 months
About Caroline Litchfield's insider trades
Caroline Litchfield is EVP & CFO at Merck (MRK). Since Nov 4, 2021, Caroline has reported no open-market purchases and 3 sales worth $11.5M on SEC Form 4. In the last 12 months: 1 sale ($5.0M).
Their filings also include grants and awards (14 filings), option exercises (8 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.